Cross Border Resources Inc. (XBOR) Announces Multimillion Budget for Second Half Drilling
Located in San Antonio, Texas, Cross Border has quickly made a name for themselves as a leading oil and gas…
Blog
Daybreak Oil and Gas, Inc. (DBRM) Secures Financing for Oil and Gas Project
Daybreak Oil and Gas, Inc. reported that the company has secured financing through a loan commitment agreement with an unidentified…
Solar Energy Initiatives, Inc. (SNRY) is “One to Watch”
Solar Energy Initiatives, Inc. is a developer of solar photovoltaic installations. The Company provides these services through their wholly owned…
Inergetics, Inc. (NRTI) is “One to Watch”
Inergetics, Inc. is a leading developer of nutritional supplements for the Clinical Nutrition and Sports Supplement markets. The Company has…
Local.com Corp. (LOCM) Appoints Mark Wallin as Vice President, Product Development
Today, leading online local media company, Local.com Corp., announced that Mark Wallin has been appointed to be the company’s new…
Eagle Ford Oil & Gas Corp. (ECCE) Announces Acquisition of Sandstone Energy, LLC
Yesterday, Eagle Ford Oil & Gas Corp. announced that they acquired Sandstone Energy, LLC, in exchange for 17,857,113 shares of…
Sky Power Solutions (SPOW) Enters Into Research and Development Phase for Residential Electric Power Station
Sky Power Solutions, a company that engages in developing rechargeable lithium-ion batteries for power production in the U.S., has announced…
BioSolar, Inc. (BSRC) Awarded Application Approval for USDA’s BioPreferred Product Label
BioSolar develops technology designed to produce bio-based materials from renewable plant sources that reduce the cost of photovoltaic (PV) solar…
ENSERVCO Corp. (ENSV) Purchases North Dakota Acreage, Prepares for New Operations Center
ENSERVCO Corp., a provider of well-site services to the domestic onshore oil and gas industry, today announced its purchase of…
Cytokinetics Inc. (CYTK) Initiates Enrollment for Phase II Clinical Trial of Lead Drug Candidate
Cytokinetics Inc., a clinical-stage biopharmaceutical company, today announced it has initiated enrollment for a second phase II clinical trial of…